Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma-Reference-Cited by-同舟云学术

Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma

Published:1980-05 Issue:5 Volume:16 Page:617-621
ISSN:0014-2964
Container-title:European Journal of Cancer (1965)
language:en
Short-container-title:European Journal of Cancer (1965)

Author:

Cavalli F.,Goldhirsch A.,Siegenthaler P.,Kaplan S.,Beer M.

Publisher

Elsevier BV

Subject

General Medicine

Reference13 articles.

1. Cis-diamminedichloroplatinum (II), A new anticancer drug;Rozencweig;Ann. intern. Med.,1977

2. Neue Substanzen in der onkologischen Therapie;Cavalli;Dtsch. med. Wschr.,1978

3. Phase II evaluation of cis-diamminedichloroplatinum (II) in lung cancer;Rossof;Cancer Treat. Rep.,1976

4. Cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study;Dombernowsky;Cancer Treat. Rep.,1979

5. Cis-dichlorodiammineplatinum (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum (II), adriamycin and cyclophosphamide in combination for adenocarcinoma of the lung;Britell;Cancer Treat. Rep.,1978

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Oral Platinum Drug JM216 as First-Line Treatment in Patients With Small-Cell Lung Cancer;Journal of Clinical Oncology;1999-12

2. Cisplatin—5-fluorouracil in small cell lung cancer. A Phase II study in 109 patients;Lung Cancer;1994-09

3. Cisplatinum and 5-Fluorouracil in small cell lung cancer;Cancer Treatment An Update;1994

4. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay;Cancer Chemotherapy and Pharmacology;1991

5. A Phase II Trial of Carboplatin (CBDCA) in Small-Cell and Non-Small-Cell Lung Cancer with Correlation to In Vitro Analysis of Cytotoxicity;American Journal of Clinical Oncology;1990-08